Baker Tilly Wealth Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Baker Tilly Wealth Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 12, 2023	SELL	$107.32 - $113.5 $553,663 - $585,546	-5,159 Reduced 46.67%	5,896 $643,000
Q4 2022 Jan 26, 2023	SELL	$62.39 - $113.8 $274,827 - $501,289	-4,405 Reduced 28.49%	11,055 $0
Q3 2022 Oct 20, 2022	SELL	$58.92 - $84.67 $48,373 - $69,514	-821 Reduced 5.04%	15,460 $957,000
Q2 2022 Jul 28, 2022	BUY	$79.4 - $116.36 $162,611 - $238,305	2,048 Added 14.39%	16,281 $1.3 Million
Q1 2022 Apr 27, 2022	SELL	$86.42 - $109.81 $2,851 - $3,623	-33 Reduced 0.23%	14,233 $1.5 Million

Q4 2021 Feb 08, 2022	BUY	$98.56 - $119.91 $68,302 - $83,097	693 Added 5.11%	14,266 $1.54 Million
Q3 2021 Nov 02, 2021	BUY	$91.91 - $110.37 $568,279 - $682,417	6,183 Added 83.67%	13,573 $1.49 Million
Q2 2021 Jul 30, 2021	BUY	$86.24 - $95.92 $89,344 - $99,373	1,036 Added 16.3%	7,390 $692,000
Q1 2021 Apr 28, 2021	BUY	$71.83 - $95.48 $56,027 - $74,474	780 Added 13.99%	6,354 $585,000
Q4 2020 Feb 03, 2021	BUY	$67.0 - $84.39 $373,458 - $470,389	5,574 New	5,574 $408,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Baker Tilly Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Baker Tilly Wealth Management, LLC with notifications on news.